Search results
Embecta touts its insulin patch pump at ADA
MedTech Dive via Yahoo Finance· 5 hours agoThe other abstract considered whether a 200-unit or 300-unit reservoir would be sufficient for that cohort of adults, assuming a mean daily dose of 96...
Beyond Weight Management: 5 Other Potential Benefits of Semaglutide
Health via Yahoo News· 49 minutes agoSemaglutide, the active compound in Wegovy and Ozempic, has been approved for weight management and...
New weight loss drugs are coming, and they could burn more fat with fewer side effects
NBC News via Yahoo News· 2 days agoLinong Ji, director of the Peking University Diabetes Center, who presented the findings. That was...
Sleep apnea patients can rest easier after possible meds breakthrough
dpa international via Yahoo News· 1 day agoA diabetes drug doubles-up as a sleep apnea treatment, a San Diego-based team of scientists say in...
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
Motley Fool via Yahoo Finance· 3 hours agoIt's obvious why Pfizer (NYSE: PFE) is eager to produce a medicine like Wegovy, Novo Nordisk's...
Trial Points to Best Practices for Inhaled Insulin in Type 1 Diabetes
MedPage Today· 2 days agoOverall glycemic control was similar between treatments, with an HbA1c at 17 weeks of 7.6% on the...
Ozempic's Novo to invest $4.1B in another US factory
InvestmentNews· 6 hours agoThe facility will add 1,000 jobs, the Danish drugmaker said Monday. The new US site is the latest in a series of multibillion-dollar investments into...
COVID is bouncing back this summer. Here’s what to know
Los Angeles Times· 3 hours agoSummer just started, but California’s not-too-surprising seasonal COVID bump is already going...
WHO issues warning on falsified medicines used for diabetes treatment and weight loss
World Health Organization· 5 days agoThe World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the...
SELECT: Semaglutide Reduces CV Events and Diabetes Risk
Medscape· 2 days agoThe glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced...
